National guidelines for colorectal cancer screening in Saudi Arabia: Recommendations from the multi-society guideline development task force
Year: 2026
Type: article
Abstract: These updated national guidelines were developed jointly by the Saudi Gastroenterology Association, Saudi Society of Colon and Rectal Surgery, Saudi Society of Gastrointestinal Oncology, and Saudi Society of Family and Community Medicine, and provide evidence-based recommendations for colorectal cancer (CRC) screening in Saudi Arabia, superseding the 2015 national guidelines. This update incorporates new epidemiological data from Saudi Arabia, including updated incidence estimates, polyp prevalence studies, colonoscopy quality audit data, and national screening uptake surveys, to provide a comprehensively evidence-anchored and locally contextualized framework. A national multidisciplinary group formulated 25 key Population, Intervention, Comparison, Outcome (PICO) questions across seven domains. Systematic literature searches were performed from inception to March 2026. Grading of Recommendations Assessment, Development and Evaluation (GRADE) evidence profiles were prepared for critical outcomes, and recommendations were developed through an iterative consensus process requiring ≥80% agreement for strong recommendations. The Task Force strongly recommends implementing an organized national CRC screening program for all asymptomatic average-risk adults aged 45 to 75 years. Biennial fecal immunochemical testing (FIT) is recommended as the primary population-based screening modality. Colonoscopy every 10 years is a recommended alternative. All positive FIT results must be followed by timely, high-quality colonoscopy. Specific recommendations are provided for high-risk groups. High-certainty evidence from multiple randomized trials and large-scale implementation studies demonstrates that organized CRC screening substantially reduces CRC-specific mortality and incidence. A phased, FIT-based national implementation strategy is recommended, tailored to Saudi epidemiology, population preferences, and healthcare infrastructure, with iterative quality improvement as new evidence emerges.
Authors: Majid A. Almadi, Resheed Alkhiari, Ammar Alotaibi, Fahad Alsohaibani, Ahmad Bazarbashi, Adel Alghamdi, Turki Alameel, Eman Al Sulais, Majid Alsahafi, Sarah Alghamdi, Faisal Batwa, Abdulaziz Almasood, Naser Alsanea, Mohammed Alghamdi, Fahad Ibnshamsah, Samar Alhomoud, Thamer Bin Traiki, Mohammed Alateeq, Mohammed Alzahrani, Abdulaziz M Alrabiah, Ghada F. Al Yousif, Abdulaziz I. Alalwan, Aymen Almuhaidb, Ohoud Alamoudi, Malak A. AlShammari, Abdullah Almousa, Abdulrahman M. Aljebreen
Institutions: King Saud Medical City, King Saud University, King Faisal Specialist Hospital & Research Centre, King Fahd Medical City, King Fahad Specialist Hospital, King Abdulaziz University, King Saud bin Abdulaziz University for Health Sciences, Prince Sultan Military Medical City, Princess Nourah bint Abdulrahman University, King Abdulaziz Medical City, National Guard Health Affairs, Umm al-Qura University, Ministry of Health, Imam Abdulrahman Bin Faisal University
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: diamond
OpenAlex ID: W7235934925
